Siemens 2008 Annual Report Download - page 70

Clinical laboratory diagnostics is a stable and growing industry. Due to multi-year customer con-
tracts and proprietary reagents for systems, approximately 80 percent of our revenue base is
recurring. We expect growth to be spurred by the expanding and aging population, the develop-
ment of new tests and increasing demand in emerging markets.
Both complex tests and those as ordinary as urine-strip tests have enormous potential: approxi-
mately 70 percent of all medical decisions are based on diagnostic test results. With the right diag-
nostic tools, many conditions such as cancer, cardiovascular disease and kidney failure can be
detected at an early stage, making it possible to improve the quality of patient care while lowering
healthcare spending. Diagnostic tests are also used to monitor patient therapy – for instance, by
tracking the efcacy of anti-coagulant drugs – thus ensuring that patient treatments are having
the desired effect.
Our customers benet from our solutions in several ways. Offering over 900 tests, we boast the
industry’s largest diagnostic test menu, encompassing dozens of disease states. We also offer a
comprehensive portfolio of analyzers capable of serving laboratories of any size, focusing on help-
ing customers improve both the efciency of their labs and the quality of patient care. Our Dimen-
sion family of products is a good example: uniquely integrating the functionality of multiple
instruments into a single system, the Dimension family is enabling clinical laboratories to save
valuable space, minimize labor costs and reduce the time needed to produce patient test results.
The success of this approach is measurable: over the last ten years the share of integrated systems
in the U.S. hospital market has grown from zero to 53 percent. Our Division, which was created by
the merger of Diagnostic Products Corporation, Bayer HealthCare Diagnostics Division and Dade
Behring, produces at least 80 percent of these systems.
The global in-vitro diagnostics market exceeds €20 billion, and, with a 17 percent market share,
Siemens Healthcare Diagnostics holds the leading position. We boast nearly 15,000 employees
and approximately 30,000 customers. Well over 125,000 of our instruments have been installed
worldwide.
Diagnostics
Donal Quinn
CEO
www.siemens.com/healthcare
We develop and market systems and reagents that generate clinical
diagnostic test results using tissue and uid analysis – a process
known as in-vitro diagnostics. This information helps physicians make
diagnoses, manage patient conditions and monitor medical therapies
in areas such as diabetes, cardiovascular disease and bleeding disor-
ders. Our solutions range from point-of-care applications to hospital,
specialty and reference laboratory systems, producing high-quality
outcomes that save time, money and lives.
64 Products and solutions – Healthcare Sector